Cardiovascular · 2024

FDA-cleared AI devices for cardiovascular 2024

2024 has 15 cardiovascular AI devices, 28.6% fewer than 2023 (21). That is 9.7% of the 154 cardiovascular devices on the FDA list, and 6.4% of all AI-device decisions dated 2024. The most active were AliveCor, Inc. (2), Ultromics Limited (2), AgileMD, Inc. (1). The newest is DeepRhythmAI from Medicalgorithmics S.A., decided on December 4, 2024.

152024 devices
13Companies
6.4%Of all 2024 AI devices
9.7%Of all cardiovascular

By month

Jan: 1Feb: 0Mar: 1Apr: 2May: 1Jun: 4Jul: 0Aug: 2Sep: 1Oct: 0Nov: 2Dec: 1
JanFebMarAprMayJunJulAugSepOctNovDec
Cardiovascular AI devices by month in 2024: Jan 1, Feb 0, Mar 1, Apr 2, May 1, Jun 4, Jul 0, Aug 2, Sep 1, Oct 0, Nov 2, Dec 1

All 15 devices

Frequently asked questions

How many FDA-cleared AI cardiovascular devices were there in 2024?

15 AI-enabled cardiovascular devices have a final decision dated 2024, from 13 companies.

How does 2024 compare with 2023 for AI cardiovascular devices?

2024 has 15 cardiovascular AI devices, 28.6% fewer than 2023 (21).

Which companies cleared the most AI cardiovascular devices in 2024?

AliveCor, Inc. (2), Ultromics Limited (2), AgileMD, Inc. (1).

What was the most recent AI cardiovascular device in 2024?

DeepRhythmAI from Medicalgorithmics S.A. (K241197), decided on December 4, 2024. Product code DQK.

Which product codes were most common for AI cardiovascular devices in 2024?

DQK (Computer, Diagnostic, Programmable): 2; QNL (Medium-Term Adjunctive Predictive Cardiovascular Indicator): 2; DPS (Electrocardiograph): 1.

Cite as: AI Device Radar, “FDA-cleared AI devices for cardiovascular 2024,” https://ai-device-radar.vercel.app/specialty/cardiovascular/2024 (FDA list through 2026-06-29).